Northwest Oncology LLC
Dyer, Indiana, United States
Oncologist in Dyer, Indiana
1001 Calumet Ave, Dyer, IN 46311
About Northwest Oncology LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
9
Alliance for Clinical Trials in Oncology
2
ECOG-ACRIN Cancer Research Group
2
Genentech, Inc.
1
NRG Oncology
1
Novartis Pharmaceuticals
1
Clinical Trials at Northwest Oncology LLC
During the past decade, Northwest Oncology LLC conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on
average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC
2016-11-30
2022-12-03
Completed
3,246
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
2019-03-12
2024-04-30
Active, not recruiting
600
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
2019-07-16
2023-06-30
Active, not recruiting
810
Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
2019-06-27
2023-09-01
Active, not recruiting
249
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
2019-12-16
2027-04-30
Recruiting
1,408
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Northwest Oncology LLC" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 2 trials
sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "NRG Oncology"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Oncology LLC"
#1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Northwest Oncology LLC
According to Clinical.Site data, the most researched conditions in "Northwest Oncology LLC" are
"Endometrial Serous Adenocarcinoma" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials) and "ALK Positive" (1 trials). Many other conditions were trialed in "Northwest Oncology LLC" in a lesser frequency.
Clinical Trials Intervention Types at Northwest Oncology LLC
Most popular intervention types in "Northwest Oncology LLC" are "Drug" (16 trials), "Other" (11 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Paclitaxel" (6 trials), "Questionnaire Administration" (6 trials), "Computed Tomography" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Northwest Oncology LLC
The vast majority of trials in "Northwest Oncology LLC" are
13 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Northwest Oncology LLC
Currently, there are NaN active trials in "Northwest Oncology LLC".
undefined are not yet recruiting,
11 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Northwest Oncology LLC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Northwest Oncology LLC, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Northwest Oncology LLC
Northwest Oncology LLC has several departments that took part in Clinical trials: "Northwest Cancer Center - Main Campus" - 14 trials
Departments List
Name
City
Trials